Effect of the antihypoxant-sodium hydroxybutyrate on visual functions and oxidative processes in glaucoma patients.

R B Zaretskaya, K V Trutneva, A V Suprun, R U Ostrovskaya, M I Shmaryan
{"title":"Effect of the antihypoxant-sodium hydroxybutyrate on visual functions and oxidative processes in glaucoma patients.","authors":"R B Zaretskaya,&nbsp;K V Trutneva,&nbsp;A V Suprun,&nbsp;R U Ostrovskaya,&nbsp;M I Shmaryan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This paper presents the results of the application of sodium hydroxybutyrate as 5% sugar syrup for the treatment of glaucoma patients. Common ophthalmological investigation methods and the oxyhemography were used. Fifty-two primary glaucoma patients (99 eyes) in various stages of disease and with different intraocular pressure levels were investigated. It was found that due to sodium hydroxybutyrate in 36 patients (69%) with statistical significance the visual field limits enlarged; in 15 patients visual acuity improved. The drug was efficient in the initial and developed glaucoma with normalized ophthalmotonus level. Significant improvement of the oxygen metabolism--oxygen saturation level of arterial blood and compensatory mechanisms functions of oxygenation-reduction processes in the majority of the patients was found. On the ground of the obtained findings the authors make a conclusion about the expediency of including 5% sodium hydroxybutyrate syrup in the complex treatment of primary glaucoma patients.</p>","PeriodicalId":79237,"journal":{"name":"Metabolic, pediatric, and systemic ophthalmology","volume":"7 4","pages":"189-94"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic, pediatric, and systemic ophthalmology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This paper presents the results of the application of sodium hydroxybutyrate as 5% sugar syrup for the treatment of glaucoma patients. Common ophthalmological investigation methods and the oxyhemography were used. Fifty-two primary glaucoma patients (99 eyes) in various stages of disease and with different intraocular pressure levels were investigated. It was found that due to sodium hydroxybutyrate in 36 patients (69%) with statistical significance the visual field limits enlarged; in 15 patients visual acuity improved. The drug was efficient in the initial and developed glaucoma with normalized ophthalmotonus level. Significant improvement of the oxygen metabolism--oxygen saturation level of arterial blood and compensatory mechanisms functions of oxygenation-reduction processes in the majority of the patients was found. On the ground of the obtained findings the authors make a conclusion about the expediency of including 5% sodium hydroxybutyrate syrup in the complex treatment of primary glaucoma patients.

抗低氧剂羟基丁酸钠对青光眼患者视觉功能和氧化过程的影响。
本文介绍了5%羟丁酸钠糖浆治疗青光眼的效果。采用常规眼科检查方法及血氧描记术。本文对52例不同阶段、不同眼压水平的原发性青光眼患者(99只眼)进行了研究。结果发现,36例(69%)患者因羟基丁酸钠导致视野范围扩大,差异有统计学意义;15例患者视力改善。该药对初期和发展为正常眼动水平的青光眼有效。大多数患者的氧代谢-动脉血氧饱和度水平和氧还原过程的代偿机制功能均有显著改善。在此基础上,作者得出了5%羟丁酸钠糖浆在原发性青光眼综合治疗中的可行性结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信